Dendritic cells: A doubleedge sword in autoimmune responses

Frontiers in Immunology

Volumn 3, Issue AUG, 2012, Pages

  Amodio, Giada ^a   Gregori, Silvia ^a  

^a SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Autoimmune diseases; Dendritic cells; Tolerance

Indexed keywords

EID: 84872175112     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00233     Document Type: Article

References (113)

1. Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of immunity. Nature 392, 245-252.
2. Baumgart, D. C., Metzke, D., Guckelberger, O., Pascher, A., Grotzinger, C., Przesdzing, I., Dorffel, Y., Schmitz, J., and Thomas, S. (2011). Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis. Clin. Exp. Immunol. 166, 46-54.
3. Begue, B., Verdier, J., Rieux-Laucat, F., Goulet, O., Morali, A., Canioni, D., Hugot, J. P., Daussy, C., Verkarre, V., Pigneur, B., Fischer, A., Klein, C., Cerf-Bensussan, N., and Ruemmele, F.M.(2011).DefectiveIL10signaling defining a subgroup of patients with inflammatory bowel disease. Am. J. Gastroenterol. 106, 1544-1555.
4. Belz, G. T., and Nutt, S. L. (2012). Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 12,101-113.
5. Boks, M. A., Kager-Groenland, J. R., Haasjes, M. S., Zwaginga, J. J., Van Ham, S. M., and Ten Brinke, A. (2012). IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction -a comparativestudyof humanclinicalapplicable DC. Clin. Immunol. 142, 332-342.
6. Bonasio, R., Scimone, M. L., Schaerli, P., Grabie, N., Lichtman, A. H., and Von Andrian, U. H. (2006). Clonal deletion of thymocytes by circulating dendriticcellshomingtothethymus. Nat. Immunol. 7,1092-1100.
7. Brocker, T., Riedinger, M., and Karjalainen, K. (1997). Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J. Exp. Med. 185,541-550.
8. Cao, W., and Bover, L. (2010). Signaling and ligand interaction of ILT7: receptormediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol. Rev. 234,163-176.
9. Carosella, E. D., Gregori, S., and Lemaoult, J. (2011). The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells. Blood 118, 6499-6505.
10. Charbonnier, L. M., van Duivenvoorde, L. M., Apparailly, F., Cantos, C., Han, W. G., Noel, D., Duperray, C., Huizinga, T. W., Toes, R. E., Jorgensen, C., and Louis-Plence, P. (2006). Immature dendritic cells suppress collageninduced arthritis by in vivo expansion of CD49b+ regulatory T cells. J. Immunol. 177, 3806-3813.
11. Cohen, R. D., Tsang, J. F., and Hanauer, S. B. (2000). Infliximab in Crohn's disease: first anniversary clinical experience. Am. J. Gastroenterol. 95, 3469-3477.
12. Colonna, M., Trinchieri, G., and Liu, Y. J. (2004). Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5, 1219-1226.
13. de Baey, A., Mende, I., Baretton, G., Greiner, A., Hartl, W. H., Baeuerle, P. A., and Diepolder, H. M. (2003). A subsetof human dendritic cells in the T cell area of mucosaassociated lymphoid tissue with a high potential to produceTNF-alpha. J. Immunol. 170, 5089-5094.
14. Demedts, I. K., Brusselle, G. G., Vermaelen, K. Y., and Pauwels, R. A. (2005). Identification and characterization of human pulmonary dendritic cells. Am. J. Respir. Cell Mol. Biol. 32,177-184.
15. de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., and De Vries, J. E. (1991). Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigenspecific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.J.Exp. Med. 174, 915-924.
16. Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., and Bhardwaj,N. (2001).Antigenspecific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193, 233-238.
17. Ding, D., Mehta, H., Mccune, W. J., and Kaplan, M. J. (2006). Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 177, 5878-5889.
18. Dzionek, A., Fuchs, A., Schmidt, P., Cremer, S., Zysk, M., Miltenyi, S., Buck, D. W., and Schmitz, J. (2000). BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood. J. Immunol. 165, 6037-6046.
19. Dzionek, A., Sohma, Y., Nagafune, J., Cella, M., Colonna, M., Facchetti, F., Gunther, G., Johnston, I., Lanzavecchia, A., Nagasaka, T., Okada, T., Vermi, W., Winkels, G., Yamamoto, T., Zysk, M., Yamaguchi, Y., and Schmitz, J. (2001). BDCA-2, a novel plasmacytoid dendritic cellspecific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J. Exp. Med. 194,1823-1834.
20. Fallarino, F., Grohmann, U., Hwang, K. W., Orabona, C., Vacca, C., Bianchi, R., Belladonna, M. L., Fioretti, M. C., Alegre, M. L., and Puccetti, P. (2003). Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4,1206-1212.
21. Fallarino, F., Vacca, C., Orabona, C., Belladonna, M. L., Bianchi, R., Marshall, B., Keskin, D. B., Mellor, A. L., Fioretti, M. C., Grohmann, U., and Puccetti, P. (2002). Functional expressionof indoleamine2,3-dioxygenasebymurineCD8alpha(+)dendritic cells. Int. Immunol. 14,65-68.
22. Feili-Hariri M., Falkner D.H., Morel P.A.(2002).Regulatory Th2 response induced following adoptive transfer of dendritic cells in prediabetic NOD mice.Eur.J.Immunol.32 2021-2030.
23. Fiorentino,D.F.,Zlotnik,A.,Mosmann, T. R., Howard, M., and O'Garra, A. (1991a). IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147,3815-3822.
24. Fiorentino, D. F., Zlotnik, A., Vieira, P., Mosmann, T.R., Howard, M., Moore, K.W., and O'Garra, A. (1991b). IL-10 acts on the antigenpresenting cell to inhibit cytokine production by Th1 cells. J. Immunol. 146,3444-3451.
25. Fransen, J. H., Hilbrands, L. B., Ruben, J., Stoffels, M., Adema, G. J.,Van Der Vlag, J., and Berden, J. H. (2009). Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17. Arthritis Rheum. 60, 2304-2313.
26. Geissmann, F., Dieu-Nosjean, M. C., Dezutter, C., Valladeau, J., Kayal, S., Leborgne, M., Brousse, N., Saeland, S., and Davoust, J.(2002).Accumulation of immature Langerhans cells in humanlymphnodesdrainingchronically inflamed skin. J. Exp. Med. 196, 417-430.
27. Gerl, V., Lischka, A., Panne, D., Grossmann, P., Berthold, R., Hoyer, B. F., Biesen, R., Bruns, A., Alexander, T., Jacobi, A., Dorner, T., Burmester, G. R., Radbruch, A., and Hiepe, F. (2010). Blood dendritic cells in systemic lupus erythematosusexhibitalteredactivationstateand chemokine receptor function. Ann. Rheum. Dis. 69,1370-1377.
28. Glocker, E. O., Frede, N., Perro, M., Sebire, N., Elawad, M., Shah, N., and Grimbacher, B. (2010). Infant colitis -it's in the genes. Lancet 376, 1272.
29. Glocker, E. O., Kotlarz, D., Boztug, K., Gertz, E. M., Schaffer, A. A., Noyan, F., Perro, M., Diestelhorst, J., Allroth, A., Murugan, D., Hatscher, N., Pfeifer, D., Sykora, K. W., Sauer, M., Kreipe, H., Lacher, M., Nustede, R., Woellner, C., Baumann, U., Salzer, U., Koletzko, S., Shah, N., Segal, A. W., Sauerbrey, A., Buderus, S., Snapper, S. B., Grimbacher, B., and Klein,C.(2009).Inflammatorybowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045.
30. Goodnow, C. C., Sprent, J., Fazekas De St Groth, B., and Vinuesa, C. G. (2005). Cellular and genetic mechanisms of self tolerance and autoimmunity. Nature 435,590-597.
31. Gorelik, L., and Flavell, R. A. (2002). Transforming growth factorbeta in T-cell biology. Nat. Rev. Immunol. 2, 46-53.
32. Gregori, S. (2011). Dendritic cells in networks of immunological tolerance. Tissue Antigens 77,89-99.
33. Gregori, S., Tomasoni, D., Pacciani, V., Scirpoli, M., Battaglia, M., Magnani, C. F., Hauben, E., and Roncarolo, M. G. (2010). Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway. Blood 116,935-944.
34. Grohmann, U., Orabona, C., Fallarino, F., Vacca, C., Calcinaro, F., Falorni, A., Candeloro, P., Belladonna, M. L., Bianchi, R., Fioretti, M. C., and Puccetti, P. (2002). CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat. Immunol. 3,1097-1101.
35. Hanabuchi, S., Ito, T., Park, W. R., Watanabe, N., Shaw, J. L., Roman, E., Arima, K., Wang, Y. H., Voo, K. S., Cao,W.,andLiu,Y.J.(2010). Thymic stromal lymphopoietinactivated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus. J. Immunol. 184,2999-3007.
36. Harry, R. A., Anderson, A. E., Isaacs, J. D., and Hilkens, C. M. (2010). Generation and characterisation of therapeutic tolerogenic dendritic cells for rheumatoid arthritis. Ann. Rheum. Dis. 69,2042-2050.
37. Hart, A. L., Al-Hassi, H. O., Rigby, R. J., Bell, S. J., Emmanuel, A. V., Knight, S. C., Kamm, M. A., and Stagg, A. J. (2005). Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129, 50-65.
38. Hawiger, D., Inaba, K., Dorsett,Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., and Nussenzweig, M. C. (2001). Dendritic cells induce peripheral T cell unresponsivenessundersteadystateconditions in vivo. J. Exp. Med. 194, 769-779.
39. Herrmann, M., Voll, R. E., Zoller, O. M., Hagenhofer, M., Ponner, B. B., and Kalden, J.R.(1998). Impairedphagocytosis of apoptotic cell material by monocytederived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 41, 1241-1250.
40. Hogquist, K. A., Baldwin, T. A., and Jameson, S. C. (2005). Central tolerance: learning selfcontrol in the thymus. Nat. Rev. Immunol. 5, 772-782.
41. Iliev, I. D., Mileti, E., Matteoli, G., Chieppa, M., and Rescigno, M. (2009). Intestinal epithelial cells promote colitisprotective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol. 2, 340-350.
42. Jaensson, E., Uronen-Hansson, H., Pabst, O., Eksteen, B., Tian, J., Coombes,J.L.,Berg,P.L.,Davidsson, T., Powrie, F., Johansson-Lindbom, B., and Agace, W. W. (2008). Small intestinalCD103+dendriticcellsdisplay unique functional properties that are conserved between mice and humans. J. Exp. Med. 205, 2139-2149.
43. Jahnsen, F. L., Lund-Johansen, F., Dunne, J. F., Farkas, L., Haye, R., and Brandtzaeg, P. (2000). Experimentally induced recruitment of plasmacytoid(CD123high)dendriticcellsin humannasalallergy. J.Immunol.165, 4062-4068.
44. Jongbloed, S. L., Lebre, M. C., Fraser, A. R., Gracie, J. A., Sturrock, R. D., Tak, P. P., and Mcinnes, I. B. (2006). Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis. Arthritis Res. Ther. 8, R15.
45. Karni, A., Abraham, M., Monsonego, A., Cai, G., Freeman, G. J., Hafler, D., Khoury, S. J., and Weiner, H. L. (2006). Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. J. Immunol. 177, 4196-4202.
46. Lambrecht, B. N., and Hammad, H. (2010). The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet 376,835-843.
47. Larregina, A. T., and Falo, L. D. Jr. (2005). Changing paradigms in cutaneous immunology: adapting with dendritic cells. J. Invest. Dermatol. 124,1-12.
48. Laskarin, G., Kammerer, U., Rukavina, D., Thomson, A. W., Fernandez, N., and Blois, S. M. (2007). Antigenpresenting cells and maternofetal tolerance: an emerging role for dendritic cells. Am. J. Reprod. Immunol. 58, 255-267.
49. Lebre, M. C., Jongbloed, S. L., Tas, S. W., Smeets, T. J., Mcinnes, I. B., and Tak, P. P. (2008). Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP-dendritic cells with distinct cytokine profiles. Am. J. Pathol. 172,940-950.
50. Lebre,M.C.,andTak,P.P.(2009). Dendritic cells in rheumatoid arthritis: which subset should be used as a tool to induce tolerance? Hum. Immunol. 70,321-324.
51. Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., and Banerjee, S. (2012). Antiinterleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis. N. Engl. J. Med. 366,1190-1199.
52. Lleo,A., Selmi, C., Invernizzi, P., Podda, M., and Gershwin, M. E. (2008). The consequences of apoptosis in autoimmunity. J. Autoimmun. 31, 257-262.
53. Lowes, M. A., Chamian, F., Abello, M. V., Fuentes-Duculan, J., Lin, S. L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Wittkowski, K. M., Papp, K., Garovoy, M., Dummer, W., Steinman,R.M.,and Krueger,J.G.(2005). Increase in TNF-alpha and inducible nitric oxide synthaseexpressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. U.S.A. 102, 19057-19062.
54. MacDonald, K. P., Munster, D. J., Clark, G. J., Dzionek, A., Schmitz, J., and Hart, D. N. (2002). Characterization of human blood dendritic cell subsets. Blood 100, 4512-4520.
55. Maniecki, M.B., Moller, H.J., Moestrup, S.K., and Moller, B.K. (2006). CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. Immunobiology 211, 407-417.
56. Martin-Gayo, E., Sierra-Filardi, E., Corbi, A. L., and Toribio, M. L. (2010). Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood 115,5366-5375.
57. Massarotti, E. M. (2008). Clinical and patientreportedoutcomesinclinical trials of abatacept in the treatment of rheumatoid arthritis. Clin. Ther. 30, 429-442.
58. Mellor, A. L., and Munn, D. H. (2004). IDOexpressionbydendriticcells:tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774.
59. Menges, M., Rossner, S., Voigtlander, C., Schindler, H., Kukutsch, N. A., Bogdan, C., Erb, K., Schuler, G., and Lutz, M. B. (2002). Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigenspecific protection of mice fromautoimmunity.J.Exp.Med.195, 15-21.
60. Merad, M., Ginhoux, F., and Collin, M. (2008). Origin, homeostasis and function of Langerhans cells and other langerinexpressing dendritic cells. Nat. Rev. Immunol. 8, 935-947.
61. Migita, K., Miyashita, T., Maeda, Y., Kimura, H., Nakamura, M., Yatsuhashi,H.,Ishibashi,H.,andEguchi, K. (2005). Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus.Clin.Exp. Immunol.142, 84-91.
62. Moreau, A., Hill, M., Thebault, P., Deschamps, J. Y., Chiffoleau, E., Chauveau, C., Moullier, P., Anegon, I., Alliot-Licht, B., and Cuturi, M. C. (2009). Tolerogenic dendritic cells actively inhibit T cells through heme oxygenase-1 in rodents and in nonhuman primates. FASEB J. 23, 3070-3077.
63. Moreau,P.,Adrian-Cabestre,F.,Menier, C., Guiard, V., Gourand, L., Dausset, J.,Carosella,E.D.,andPaul,P.(1999). IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int. Immunol. 11, 803-811.
64. Morelli, A. E., and Thomson, A. W. (2007). Tolerogenic dendritic cells and the quest for transplant tolerance. Nat. Rev. Immunol. 7,610-621.
65. Mori, M., Pimpinelli, N., Romagnoli, P., Bernacchi, E., Fabbri, P., and Giannotti, B. (1994). Dendritic cells in cutaneous lupus erythematosus: a clue to the pathogenesis of lesions. Histopathology 24,311-321.
66. Mosser, D. M., and Zhang, X. (2008). Interleukin-10: new perspectives on an old cytokine. Immunol. Rev. 226, 205-218.
67. Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., Burg, G., Liu, Y. J., and Gilliet, M. (2005). Plasmacytoid predendritic cells initiate psoriasis through interferonalpha production. J. Exp. Med. 202,135-143.
68. Niu, X., He, D., Deng, S., Li, W., Xi, Y., Xie, C., Jiang, T., Zhang, J. Z., Dong, C., and Chen, G. (2011). Regulatory immune responses induced by IL-1 receptor antagonist in rheumatoid arthritis. Mol. Immunol. 49,290-296.
69. Ohnmacht, C., Pullner, A., King, S. B., Drexler, I., Meier, S., Brocker, T., and Voehringer, D. (2009). Constitutive ablation of dendritic cells breaks selftolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J. Exp. Med. 206,549-559.
70. Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., and Choi, A. M. (2000). Carbon monoxide has antiinflammatory effects involving the mitogenactivated protein kinase pathway. Nat. Med. 6,422-428.
71. Pacciani, V., Gregori, S., Chini, L., Corrente, S., Chianca, M., Moschese, V., Rossi, P., Roncarolo, M. G., and Angelini, F. (2010). Induction of anergicallergenspecificsuppressorT cells using tolerogenic dendritic cells derived from children with allergies to house dust mites. J. Allergy Clin. Immunol. 125,727-736.
72. Pae, H. O., Oh, G. S., Choi, B. M., Chae, S. C., Kim, Y. M., Chung, K. R., and Chung, H. T. (2004). Carbonmonoxideproducedbyheme oxygenase-1 suppresses T cell proliferationviainhibitionof IL-2production. J. Immunol. 172, 4744-4751.
73. Papp, K. A., Leonardi, C., Menter, A., Ortonne, J. P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H., and Baumgartner,S.(2012).Brodalumab, an antiinterleukin-17-receptor antibody for psoriasis. N. Engl. J. Med. 366,1181-1189.
74. Pashenkov, M., Teleshova, N., Kouwenhoven, M., Kostulas, V., Huang, Y. M., Soderstrom, M., and Link, H. (2002). Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis. Clin. Exp. Immunol. 127,519-526.
75. Pene, J., Chevalier, S., Preisser, L., Venereau, E., Guilleux, M. H., Ghannam, S., Moles, J. P., Danger, Y., Ravon, E., Lesaux, S., Yssel, H., and Gascan, H. (2008). Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180, 7423-7430.
76. Penna, G., and Adorini, L. (2000). 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405-2411.
77. Pettit, A. R., MacDonald, K. P., O'Sullivan, B., and Thomas, R. (2000). Differentiated dendritic cells expressing nuclear RelB are predominantly located in rheumatoid synovial tissue perivascular mononuclear cell aggregates. Arthritis Rheum. 43, 791-800.
78. Piemonti, L., Monti, P., Allavena, P., Sironi, M., Soldini, L., Leone, B. E., Socci, C., and Di Carlo, V. (1999). Glucocorticoids affect human dendritic cell differentiation and maturation. J. Immunol. 162, 6473-6481.
79. Present, D. H., Rutgeerts, P., Targan, S., Hanauer, S. B., Mayer, L., Van Hogezand, R. A., Podolsky, D. K., Sands,B. E.,Braakman,T.,Dewoody, K. L., Schaible, T. F., and Van Deventer, S. J. (1999). Infliximab for the treatment of fistulas in patients with Crohn's disease. N. Engl. J. Med. 340, 1398-1405.
80. Proietto,A.I.,VanDommelen,S.,Zhou, P., Rizzitelli, A., D'Amico, A., Steptoe, R. J., Naik, S. H., Lahoud, M. H., Liu, Y., Zheng, P., Shortman, K., and Wu, L. (2008). Dendritic cells in the thymus contribute to T-regulatory cell induction. Proc. Natl. Acad. Sci. U.S.A. 105, 19869-19874.
81. Rescigno, M., and Di Sabatino, A. (2009). Dendritic cells in intestinal homeostasis and disease. J. Clin. Invest. 119,2441-2450.
82. Ricart, E., Panaccione, R., Loftus, E. V., Tremaine, W. J., and Sandborn, W. J. (2001). Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients. Am. J. Gastroenterol. 96,722-729.
83. Rimoldi, M., Chieppa, M., Salucci, V., Avogadri,F.,Sonzogni,A.,Sampietro, G.M.,Nespoli,A.,Viale,G.,Allavena, P.,andRescigno,M.(2005).Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat. Immunol. 6, 507-514.
84. Robak, E., Smolewski, P., Wozniacka, A.,Sysa-Jedrzejowska,A.,Stepien,H., and Robak, T. (2004). Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus. Eur. Cytokine Netw. 15, 222-230.
85. Sakthivel, P. (2009). Bench to bedside of CTLA-4: a novel immunotherapeutic agent for inflammatory disorders. Recent Pat. Inflamm. Allergy Drug Discov.3, 84-95.
86. Salomon,B.,andBluestone,J.A.(2001). Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu. Rev. Immunol. 19,225-252.
87. Santiago-Schwarz, F. (2004). Dendritic cells: friend or foe in autoimmunity? Rheum. Dis. Clin. North Am. 30, 115-134.
88. Sato, K., Yamashita, N., Baba, M., and Matsuyama, T. (2003). Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 101, 3581-3589.
89. Schakel, K., Poppe, C., Mayer, E., Federle, C., Riethmuller, G., and Rieber, E. P. (1999). M-DC8+ leukocytes -a novel human dendritic cell population. Pathobiology 67,287-290.
90. Schwartz, R. H., Mueller, D. L., Jenkins, M. K., and Quill, H. (1989). T-cell clonal anergy. Cold Spring Harb. Symp. Quant. Biol. 54(Pt 2),605-610.
91. Seitz, H. M., and Matsushima, G. K. (2010). Dendritic cells in systemic lupus erythematosus. Int. Rev. Immunol. 29, 184-209.
92. Silva, M. A., Lopez, C. B., Riverin, F., Oligny, L., Menezes, J., and Seidman, E. G. (2004). Characterization and distribution of colonic dendritic cells in Crohn's disease. Inflamm. Bowel Dis. 10,504-512.
93. Smolen, J. S., Beaulieu, A., Rubbert-Roth, A., Ramos-Remus, C., Rovensky, J., Alecock, E., Woodworth, T., and Alten, R. (2008). Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a doubleblind, placebocontrolled, randomised trial. Lancet 371,987-997.
94. Stasiolek, M., Bayas, A., Kruse, N., Wieczarkowiecz, A., Toyka, K. V., Gold, R., and Selmaj, K. (2006). Impairedmaturationandalteredregulatory function of plasmacytoid dendritic cells in multiple sclerosis. Brain 129,1293-1305.
95. Steinbrink, K., Graulich, E., Kubsch, S., Knop, J., and Enk, A. H. (2002).CD4(+)andCD8(+)anergic T cells induced by interleukin-10-treated human dendritic cells display antigenspecific suppressor activity. Blood 99,2468-2476.
96. Steinbrink, K., Wolfl, M., Jonuleit, H., Knop, J., and Enk, A. H. (1997). Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159,4772-4780.
97. Steinman, R. M., and Nussenzweig, M. C. (2002). Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc. Natl. Acad. Sci. U.S.A. 99, 351-358.
98. Suciu-Foca,N.,Manavalan,J. S.,Scotto, L., Kim-Schulze, S., Galluzzo, S., Naiyer, A. J., Fan, J., Vlad, G., and Cortesini,R. (2005). Molecular characterizationof allospecificTsuppressor and tolerogenic dendritic cells: review. Int. Immunopharmacol. 5, 7-11.
99. Swiecki, M., and Colonna, M. (2010). Accumulation of plasmacytoid DC: roles in disease pathogenesis and targets for immunotherapy. Eur. J. Immunol. 40, 2094-2098.
100. Taga, K., and Tosato, G. (1992). IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148,1143-1148.
101. Takakubo, Y., Takagi, M., Maeda, K., Tamaki, Y., Sasaki, A., Asano, T., Fukushima, S., Kiyoshige, Y., Orui, H., Ogino, T., and Yamakawa, M. (2008). Distribution of myeloid dendritic cells and plasmacytoid dendritic cells in the synovial tissues of rheumatoid arthritis. J. Rheumatol. 35,1919-1931.
102. te Velde, A. A., Van Kooyk, Y., Braat, H., Hommes, D. W., Dellemijn, T. A., Slors, J. F., Van Deventer, S. J., and Vyth-Dreese, F. A. (2003). Increased expression of DC-SIGN+IL-12+IL-18+andCD83+ IL-12-IL-18-dendritic cell populations in the colonic mucosa of patients with Crohn's disease. Eur. J. Immunol. 33, 143-151.
103. Thomson, A. W. (2010). Tolerogenic dendritic cells: all present and correct? Am. J. Transplant. 10, 214-219.
104. Torres-Aguilar, H., Blank, M., Jara, L. J., and Shoenfeld, Y. (2010). Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity. Autoimmun. Rev. 10,8-17.
105. Vaknin-Dembinsky, A., Balashov, K., and Weiner, H. L. (2006). IL-23 is increased in dendritic cells in multiple sclerosis and downregulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J. Immunol. 176,7768-7774.
106. van Duivenvoorde, L. M., Han, W. G., Bakker, A. M., Louis-Plence, P., Charbonnier, L. M., Apparailly, F., Van Der Voort, E. I., Jorgensen, C., Huizinga, T. W., and Toes, R. E. (2007). Immunomodulatory dendritic cells inhibit Th1 responses and arthritis via different mechanisms. J. Immunol. 179,1506-1515.
107. van Duivenvoorde, L. M., Louis-Plence, P.,Apparailly, F.,Van Der Voort, E. I., Huizinga, T. W., Jorgensen, C., and Toes, R. E. (2004). Antigenspecific immunomodulation of collageninduced arthritis with tumor necrosis factorstimulated dendritic cells. Arthritis Rheum. 50, 3354-3364.
108. Vermi, W., Riboldi, E., Wittamer, V., Gentili,F.,Luini,W.,Marrelli,S.,Vecchi,A.,Franssen,J. D.,Communi,D., Massardi, L., Sironi, M., Mantovani, A., Parmentier, M., Facchetti, F., and Sozzani, S. (2005). Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 201, 509-515.
109. Vieira, P., De Waal-Malefyt, R., Dang, M. N., Johnson, K. E., Kastelein, R., Fiorentino, D. F., Devries, J. E., Roncarolo, M. G., Mosmann, T. R., and Moore, K. W. (1991). Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homologytoEpstein-Barrvirusopen reading frame BCRFI. Proc. Natl. Acad. Sci. U.S.A. 88, 1172-1176.
110. Watts, C., West, M. A., and Zaru, R. (2010).TLRsignallingregulatedantigen presentation in dendritic cells. Curr. Opin. Immunol. 22, 124-130.
111. Wu,G. F.,and Laufer,T. M. (2007). The role of dendriticcellsinmultiplesclerosis. Curr. Neurol. Neurosci. Rep. 7, 245-252.
112. Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suarez-Farinas, M., Fuentes-Duculan, J., Novitskaya,I.,Khatcherian,A.,Bluth, M. J., Lowes, M. A., and Krueger, J. G. (2007). Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 204, 3183-3194.
113. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., and Ouyang, W. (2007). Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermalinflammationandacanthosis. Nature 445,648-651.